Lyra Therapeutics (LYRA) Q4 2022 Earnings

29MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.91
-0.71
-0.52
-0.32

Details

Expected EPS
-0.41
Actual EPS
-0.32
Surprise EPS
0.09
Surprise Percent
+21.95%

Description

Lyra Therapeutics (LYRA) has reported earnings of -0.32 per share for Q4 2022.

0 Comments

Share your thoughts